A detailed history of Exchange Traded Concepts, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 196,480 shares of ROIV stock, worth $2.35 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
196,480
Holding current value
$2.35 Million
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$10.17 - $12.5 $2 Million - $2.46 Million
196,480 New
196,480 $2.27 Million
Q3 2023

Oct 18, 2023

BUY
$9.76 - $13.19 $1.69 Million - $2.28 Million
172,925 New
172,925 $2.02 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.43B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.